Release Date: July 31, 2025
Expiration Date: July 31, 2026
Activity Overview
More than 16 million adults are diagnosed with dry eye disease (DED), and an additional 6 million experience symptoms without a formal diagnosis – with the prevalence continuing to rise. In this program, learners discover new opportunities for efficiently diagnosing specific factors driving different types of DED and devising treatment strategies that address patients’ individual needs.
This educational activity is an archive of the live symposium held on June 25, 2025.
Target Audience
This educational activity is directed toward optometrists and other eye care professionals involved in the management of patients with DED.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Describe the burden of OSD, specifically DED, as it relates to patient quality of life and ocular health outcomes
- Integrate advanced diagnostic methods into the assessment of DED
- Implement individualized treatment plans for optimal management of DED
Mark Schaeffer, OD, FAAO
Clinical Excellence Captain
MyEyeDr
Birmingham, AL
Disclosures: Consultant: AbbVie, Alcon, Bausch + Lomb, CooperVision, Harrow, Orasis Pharmaceuticals, Tarsus Pharmaceuticals, Zeiss; Speakers’ Bureau: Alcon, Bausch + Lomb, Harrow, Orasis Pharmaceuticals, Tarsus Pharmaceuticals, Zeiss.
Mile Brujic, OD, FAAO
Partner
Premier Vision Group
Bowling Green, OH
Disclosures: Honoraria: ABB Optica Group, AbbVie, Alcon, Apellis Pharmaceuticals, Art Optical, Bausch + Lomb Health, Contamac, CooperVision, CSEye, Dompé, Dopavision, Glaukos, Iveric Bio, Johnson & Johnson Vision Care, Lentechs, MDElite, Nordic Pharma, Notal Vision, Orasis Pharmaceuticals, Radius XR, RVL Pharmaceuticals, Sun Pharmaceutical Industries, Tangible Science, Tarsus Pharmaceuticals, Viatris, Visionix, Walman Optical, ZeaVision.
Nate Lighthizer, OD, FAAO, FAAOMS
Professor
Dean
NSU Oklahoma College of Optometry
Tahlequah, OK
Disclosures: Consultant; Diopsys, LKC Technologies, OCUsOFT, Orasis Pharmaceuticals, Reichert Technologies, Virtual Vision; Speakers Bureau: Allergan, Avellino, Diopsys, Dompé, Ellex, iCare, Innova Systems, Lumenis, Nidek, Novartis, Optovue, Reichert Technologies, RVL Pharmaceuticals, Sight Sciences, Sun Pharmaceuticals, TRIAD Ophthalmics, Virtual Vision; Other: advisory board: Aerie Pharmaceuticals, Bausch + Lomb, Bruder Healthcare, EyePromise, Horizon Therapeutics, Ivantis, Novartis, Orasis Pharmaceuticals, Oyster Point Pharma, Sight Sciences, Tarsus, Théa Pharmaceuticals.
Selina R. McGee, OD, FAAO
Visionary Founder/Owner, BeSpoke Vision
Adjunct Faculty, Northeastern State University College of Optometry
Past-President, Intrepid Eye Society
Secretary/Treasurer, Oklahoma Board of Examiners
Edmond, OK
Disclosures: Consultant; AbbVie, Alcon, Aldeyra, Avellino, Bausch + Lomb, Bruder Healthcare, Cynosure, Dompé, Horizon, Kala, Lumenis, Novartis, Optovue, Oyster Point, RVL, ScienceBased Health, Sun Pharmaceuticals, Tarsus Pharmaceuticals, Théa Pharmaceuticals, Topcon Healthcare, Versant Health, Zeiss; Speakers Bureau: AbbVie, Alcon, Bausch + Lomb, Cynosure, Dompé, Lumenis, Oyster Point Pharma, Optovue, ScienceBased Health, Sun Pharmaceuticals, Tarsus Pharmaceuticals.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, (PER®) have no relevant financial relationships with ineligible companies.
PER mitigated all COI for faculty, staff, and planners prior to the start of this activity.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here